{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigrku5xfwcrnu2xa47tfowdwajzqwup6dehotpqzegcmpdfbeynie",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mehfmewvhsb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif2inmk3zgqvgc7hbnmpd57k4qy6xzjz6vvpqdk6okxawrfexm5ue"
    },
    "mimeType": "image/jpeg",
    "size": 288489
  },
  "path": "/news/2026-02-prescriptions-pbms-dominate-d.html",
  "publishedAt": "2026-02-09T15:20:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Medical economics"
  ],
  "textContent": "Just three pharmacy benefit managers (PBM) dominate retail prescriptions in Medicare Part D and Medicaid managed care across much of the country, with markets in nearly every state considered highly concentrated for at least one program, according to a new study from the USC Schaeffer Center for Health Policy & Economics.",
  "title": "Why your prescriptions may cost more: Three PBMs dominate most Part D markets"
}